• 专利标题:   Composite hydrogel with immune regulation function useful in construction of intervertebral disc tissue engineering materials, comprises e.g. nucleus pulposus acellular matrix, graphene oxide and hyaluronic acid.
  • 专利号:   CN112972772-A, CN112972772-B
  • 发明人:   PENG Y, SHAO Z, QING X, TIAN S, LIU S, SHU H, CHEN X, LI J
  • 专利权人:   HUST TONGJI MEDICAL COLLEGE UNION HOSPIT, HUST TONGJI MEDICAL COLLEGE UNION AFFILI
  • 国际专利分类:   A61L027/08, A61L027/20, A61L027/36, A61L027/50, A61L027/52, A61L027/54, A61L027/56, A61L027/58, C08J003/075, C08K003/04, C08K009/04, C08L005/08
  • 专利详细信息:   CN112972772-A 18 Jun 2021 A61L-027/36 202164 Pages: 16 Chinese
  • 申请详细信息:   CN112972772-A CN10178444 09 Feb 2021
  • 优先权号:   CN10178444

▎ 摘  要

NOVELTY - Composite hydrogel with immune regulation function comprises nucleus pulposus acellular matrix, graphene oxide connected to the nucleus pulposus acellular matrix by chemical cross-linking and hyaluronic acid connected to the graphene oxide by bridging. USE - The composite hydrogel is useful: in construction of intervertebral disc tissue engineering materials; in construction of composite functional material for regulating immune regulation of intervertebral disc and relieving oxidative stress (all claimed); and for regulating internal inflammation of intervertebral disc and relieving oxidative stress. ADVANTAGE - The composite hydrogel: can simulate natural nucleus pulposus tissue; and has high mechanical property and excellent stability. DETAILED DESCRIPTION - An INDEPENDENT CLAIM is also included for preparing composite hydrogel with immune regulation function, comprising (i) dispersing graphene oxide (GO) in water, adding 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC) and N-hydroxysulfosuccinimide (NHS) and adjusting the pH value to 5.5-5.8 using alkali liquid, then adding adipic acid dihydrazide (ADH) and stirring at room temperature for 24 hours to obtain GO-ADH, (ii) dissolving hyaluronic acid (HA) in water, adding EDC and NHS and adjusting the pH value to 5.5-5.8 using alkali liquid, then adding GO-ADH obtained in step (i) and stirring at room temperature for 24-28 hours to obtain GO-HA, and (iii) dissolving GO-HA obtained in step (ii) in acetic acid, mixing with GO-HA and 2,4-dinitrophenol (DNP) in a volume ratio of 1:10-30, ultrasonically processing to obtain HA-GO-DNP hydrogel, performing freeze-drying, acid treatment and digestion treatment on the obtained HA-GO-DNP hydrogel to obtain HA-GO-DNP composite hydrogel.